期刊导航 收藏 设为首页 网站地图 繁体版

ACM  >> Vol. 5 No. 2 (June 2015)

    人感染H7N9禽流感病毒的研究进展
    An Overview of the Outbreaks of the Avian-Origin In?uenza A (H7N9) Virus in the Human

  • 全文下载: PDF(380KB) HTML   XML   PP.72-77   DOI: 10.12677/ACM.2015.52013  
  • 下载量: 1,428  浏览量: 5,806  

作者:  

周婧婧,高玉敏：内蒙古医科大学，内蒙古 呼和浩特

关键词:
禽流感病毒；病原学；流行病学；临床特征；Avian Influenza Virus； Etiology； Epidemiology； Clinical Features

摘要:

新型甲型流感病毒的出现会导致流感大流行甚至暴发，2013年2月，新型甲型流感病毒H7N9在上海出现并蔓延至全国多省市。本篇文章对2013年2月以来有关H7N9病毒株的流行病学、临床表现、防治措施等相关文献进行综述，目前的数据显示，H7N9禽流感病毒通过基因突变获得人源受体，随候鸟迁徙传播给家禽。禽接触是主要传播途径。年龄、性别和基础疾患是影响预后的主要因素。对H7N9早期感染者多采取抑制剂奥司他韦和帕拉米韦治疗。目前针对H7N9的疫苗还处于实验阶段。做好持续监测和及时沟通，对于探索H7N9禽流感病毒的起源与传播途径并制定行之有效的控制措施是非常重要的。

Novel influenza A virus may cause epidemic and outbreak. In February 2013, a novel AIV (H7N9) strain was discovered in Shanghai and spreaded to several provinces. Here we reviewed the current knowledge of the virus about its epidemiology, clinical features, as well as prevention and cure measures. The data available so far indicated that H7N9 was originated by a reassortment process in birds and contained human-receptor and transmitted to humans through direct contact with live-bird markets. The severity of the respiratory disease caused by novel H7N9 virus in humans can be partly attributed to the age, sex, and underlying medical conditions of the patients. Early antiviral therapy with neuraminidase inhibitors was effective. A universal influenza vaccine is not available, constant surveillance and communication combined with novel research approaches to identify the source and mode of transmission of these viruses and develop alternative and effective anti-influenza strategies are needed to overcome influenza A (H7N9) virus.

文章引用:
周婧婧, 高玉敏. 人感染H7N9禽流感病毒的研究进展[J]. 临床医学进展, 2015, 5(2): 72-77. http://dx.doi.org/10.12677/ACM.2015.52013

参考文献

[1] 郭元吉 (2004) 人禽流感研究现状. 中华实验和临床病毒学杂志, 3, 294-295.
[2] Yang, Y., Guo, F., Zhao, W., et al. (2015) Novel avian-origin influenza A(H7N9) in critically ill patients in China. Critical Care Medicine, 43, 339-345.
[3] To, K.K., Zhang, A.J., Chan, et al. (2015) Recombinant influenza A virus hemagglutinin HA2 subunit protects mice against influenza A(H7N9) virus infection. Archives of Virology, 160, 777-786.
[4] European Centre for Disease Prevention and Control (2013) Rapid risk assessment; severe respiratory disease associated with a novel influenza A virus (H7N9) Chi-na.
[5] http://www.ecdc.europa.eu/en/publications/Publications/AH7N9-China-rapid-risk-assesement
[6] De Jong, J.C., Claas, E.C., et al. (1997) A pandemic warning? Nature, 389, 554.
[7] Fouchier, R.A., Schneeberger, et al. (2004) Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proceedings of the National Academy of Sciences of the USA, 101, 1356-1361.
[8] 陈健, 毛盛华, 胡家瑜等 (2013) 人感染H7N9禽流感流行特征与防控策略. 第二军医大学学报, 6, 585-590.
[9] 陈恩富, 柴程良, 孙继民等 (2013) 浙江省人感染H7N9禽流感流行特征与防控对策. 中国公共卫生, 5, 625-627.
[10] 江丽芳 (2013) H7N9禽流感病毒研究现状. 中山大学学报, 5, 651-656.
[11] Cowling, B.J., Jin, L.M., Lau, E.H.Y., Liao, Q.H., Wu, P., Jiang, H., et al. (2013) Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: A population-based study of laboratory-confirmed cases. The Lancet, 382, 129-137.
[12] 徐德忠, 张扬, 王波, 唐晓凤, 张景霞, 孙慧敏, 等 (2013) 人感染H7N9禽流感分布异常及其异常起源之可能. 中华疾病控制杂志, 8, 645-650.
[13] Yi, L., Guan, D., Kang, M., Wu, J., Zeng, X., Lu, J., et al. (2015) Family clusters of avian influenza A H7N9 virus infection in Guangdong province, China. Journal of Clinical Microbiology, 53, 22-28.
[14] 王世平, 曹家艳, 张仁俊, 郭黄吉, 陶宏, 吉光辉, 等 (2015) 贵州省首例输入性人感染 H7N9 禽流感病例的流行病学调查. 现代预防医学, 2, 202-204.
[15] Zeng, X., Mai, W., Shu, B., Yi, L., Lu, J., Song, T., et al. (2015) Mild influenza A/H7N9 infection among children in Guangdong province. The Pediatric Infectious Disease Journal, 34, 104-107.
[16] Ling, F., Chen, E., Liu, Q., Miao, Z. and Gong, Z. (2015) Hypothesis on the source, transmission and characteristics of infection of avian influenza A (H7N9) virus based on analysis of field epidemiological investigation and gene sequence analysis. Zoonoses and Public Health, 62, 29-37.
[17] Jernigan, D.B. and Cox, N.J. (2015) H7N9: Preparing for the unexpected in influenza. Annual Review of Medicine, 66, 361-371.
[18] Poovorawan, Y., Pyungporn, S., Prachayangprecha, S. and Makkoch, J. (2013) Global alert to avian influenza virus infection: From H5N1 to H7N9. Pathogens and Global Health, 107, 217-223.
[19] Gao, R., Cao, B., Hu, Y., Feng, Z., Wang, D., Hu, W., et al. (2013) Human infection with a novel avian-origin influenza A (H7N9) virus. The New England Journal of Medicine, 368, 1888-1897.
[20] 韩明锋, 冉献贵, 赵凤德, 程国玲, 申辉, 王瑞瑞 (2013) 国内102例人感染H7N9禽流感特点初步分析. 传染病信息, 2, 68-70.
[21] Kubo, S., Nishiguchi, S., Shuto, T., Tanaka, H., Tsukamoto, T., Hirohashi, K., et al. (1999) Effects of continuous hepatitis with persistent hepatitis C viremia on outcome after resection of hepatocellular carcinoma. Japanese Journal of Cancer Research, 90, 162-170.
[22] Shindoh, J., Hasegawa, K., Matsuyama, Y., Inoue, Y., Ishizawa, T., Aoki, T., et al. (2013) Low hepatitis C viral load predicts better long-term outcomes in patients undergoing resection of hepatocellular carcinoma irrespective of serologic eradication of hepatitis C virus. Journal of Clinical Oncology, 31, 766-773.
[23] 石伟先, 潘阳, 赵佳琛, 彭晓旻, 崔淑娟, 卢桂兰, 等 (2015) 检测基因及样本类型对人感染H7N9禽流感病毒实验室检测结果的影响. 中华疾病控制杂志, 2, 111-114.
[24] Wu, C.Y., Chang, C.Y., Ma, H.H., Wang, C.W., Chen, Y.T., Hsiao, P.W., et al. (2014) Squalene-adjuvanted H7N9 virus vaccine induces robust humoral immune response against H7N9 and H7N7 viruses. Vaccine, 32, 4485-4494.
[25] Chu, D.H, Sakoda, Y., Nishi, T., Hiono, T., Shichinohe, S., Okamatsu, M. and Kida, H. (2014) Potency of an inactivated influenza vaccine prepared from A/duck/Mongolia/119/2008 (H7N9) against the challenge with A/Anhui/1/2013 (H7N9). Vaccine, 32, 3473-3479.